Somnigroup International (SGI) AI Stock Analysis

• Market Cap: $19.12B
• Dividend Yield: 0.66%
• Average Volume (3M): 1.76M
• Price to Earnings (P/E): 59.4
• Beta (1Y): 1.01
• Revenue Growth: 39.29%
• EPS Growth: -30.44%
• Country: US
• Employees: 12,000
• Sector: N/A
• Sector Strength: N/A
• Industry: Household & Personal Products
• EPS (TTM): 0.95
• Shares Outstanding: 209,907,670
• 10 Day Avg. Volume: 1,689,112
• 30 Day Avg. Volume: 1,760,265
• PEG Ratio: 7.83
• Price to Book (P/B): 17.61
• Price to Sales (P/S): 2.00
• P/FCF Ratio: 17.29
• Enterprise Value/Market Cap: 1.11
• Enterprise Value/Revenue: 3.11
• Enterprise Value/Gross Profit: 7.35
• Enterprise Value/Ebitda: 24.72
• 1Y Price Target: $98.33
• Price Target Upside: 7.94% Upside
• Rating Consensus: Strong Buy
• Number of Analyst Covering: 8
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 72 Outperform
• Price Target: $101.00 ▲(10.87% Upside)

Somnigroup International's overall score is driven by strong technical indicators and positive earnings call sentiment. Financial performance shows growth but is offset by declining margins. The high P/E ratio suggests overvaluation, while corporate events are strategically positive.

Somnigroup International Business Overview & Revenue Model

Company Description

Somni is a company specializing in sleep technology and wellness solutions, developing innovative products to enhance sleep quality. The company integrates science-backed methods, smart technology, and data-driven insights to improve sleep patterns and overall well-being.

How the Company Makes Money

Somnigroup International generates revenue through multiple streams, primarily by selling its flagship sleep technology products, which include wearable sleep trackers, smart pillows, and sleep optimization software. Additionally, SGI offers subscription-based services for personalized sleep coaching and access to an exclusive app that provides tailored sleep improvement plans. The company has established significant partnerships with healthcare providers and wellness organizations, enabling them to reach a broader audience and integrate their products into clinical settings. Moreover, SGI earns revenue through licensing agreements with other companies in the health and wellness industry, allowing them to utilize SGI's proprietary technology and research in their own products.

Somnigroup International Financial Statement Overview

Summary

Income Statement

Balance Sheet

Cash Flow

Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Somnigroup International Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 91.10
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SGI, the sentiment is Positive. The current price of 91.1 is above the 20-day moving average (MA) of 90.20, above the 50-day MA of 86.99, and above the 200-day MA of 73.68, indicating a bullish trend. The MACD of 1.68 indicates Positive momentum. The RSI at 53.59 is Neutral, neither overbought nor oversold. The STOCH value of 50.06 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SGI.

Somnigroup International Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	―	―	―	―	―	―	―
KVUE	73 Outperform	$33.05B	23.19	13.47%	4.78%	-2.94%	34.54%
SGI	72 Outperform	$19.12B	59.41	16.47%	0.66%	39.29%	-30.44%
CHD	72 Outperform	$20.30B	26.62	18.59%	1.40%	1.45%	42.04%
CL	63 Neutral	$63.64B	22.12	450.35%	2.67%	-0.05%	2.49%
KMB	63 Neutral	$34.03B	17.37	136.87%	4.92%	-10.04%	-23.41%
CLX	55 Neutral	$12.18B	15.64	4163.16%	4.93%	-9.35%	123.06%

Somnigroup International Corporate Events

Somnigroup Proposes Acquisition of Leggett & Platt

On December 1, 2025, Somnigroup International Inc. announced a proposal to acquire Leggett & Platt in an all-stock transaction, offering a 30.3% premium to Leggett & Platt’s average closing price over the last 30 trading days. This acquisition aims to provide significant value to Leggett & Platt shareholders and enhance the growth potential of the combined company, with Leggett & Platt continuing to operate independently under Somnigroup’s umbrella.

Somnigroup International Unveils Strategic Initiatives Update

On November 6, 2025, Somnigroup International Inc. released an updated investor presentation, highlighting its strategic initiatives and market positioning. The company aims to expand its market share and enhance its consumer experience through continuous innovation and operational efficiencies. The presentation also outlined the impact of tariff-related pricing adjustments expected to affect sales in North America, with further price increases anticipated in early 2026.

Somnigroup Appoints Christopher T. Cook as Director

On September 30, 2025, Somnigroup International Inc. announced the appointment of Christopher T. Cook as an independent director, expanding its Board of Directors from seven to eight members. Mr. Cook, a seasoned retail entrepreneur with over 20 years of leadership experience, is expected to bring valuable insights from his previous roles, including his tenure at Mattress Firm, to support Somnigroup’s long-term value creation strategy.